Lombardi, Davide <br/><br/>
Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study.  [electronic resource] 

 -  Tumori   
 - 229-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0300-8916 
<br/><br/><label>Standard No.: </label>10.1177/030089161009600207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Docetaxel<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Taxoids--administration & dosage